Gregory W. Smith

601 total citations
10 papers, 474 citations indexed

About

Gregory W. Smith is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gregory W. Smith has authored 10 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Gregory W. Smith's work include Cancer Genomics and Diagnostics (3 papers), Renal cell carcinoma treatment (2 papers) and Renal and related cancers (2 papers). Gregory W. Smith is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Renal cell carcinoma treatment (2 papers) and Renal and related cancers (2 papers). Gregory W. Smith collaborates with scholars based in United States, Tanzania and Sweden. Gregory W. Smith's co-authors include Robert A. Figlin, Andrea Harzstark, Damian A. Laber, Harry A. Drabkin, Fredrik Erlandsson, Primo N. Lara, Eliezer M. Van Allen, Nikhil Wagle, Jonathan E. Rosenberg and Toni K. Choueiri and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Surface Science.

In The Last Decade

Gregory W. Smith

9 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory W. Smith United States 7 296 57 47 47 36 10 474
Charles P. Lollo United States 10 401 1.4× 48 0.8× 34 0.7× 54 1.1× 11 0.3× 16 612
Hidehiko Iwabuki Japan 10 379 1.3× 90 1.6× 19 0.4× 62 1.3× 25 0.7× 11 613
Matthew J. Rames United States 12 309 1.0× 26 0.5× 68 1.4× 109 2.3× 59 1.6× 23 617
S. Navarro Spain 11 281 0.9× 25 0.4× 33 0.7× 64 1.4× 33 0.9× 13 487
Merete K. Raarup Denmark 13 321 1.1× 21 0.4× 121 2.6× 58 1.2× 67 1.9× 23 724
William J. Foster United States 17 142 0.5× 32 0.6× 56 1.2× 77 1.6× 28 0.8× 46 699
Catherine Zandonella United States 7 148 0.5× 74 1.3× 28 0.6× 75 1.6× 51 1.4× 12 544
Matthia A. Karreman Germany 15 257 0.9× 69 1.2× 19 0.4× 106 2.3× 6 0.2× 25 633
Andreas Karner Austria 11 211 0.7× 19 0.3× 85 1.8× 110 2.3× 18 0.5× 29 386
Raghavendra Vasudeva Murthy India 12 215 0.7× 67 1.2× 32 0.7× 54 1.1× 4 0.1× 22 398

Countries citing papers authored by Gregory W. Smith

Since Specialization
Citations

This map shows the geographic impact of Gregory W. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory W. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory W. Smith more than expected).

Fields of papers citing papers by Gregory W. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory W. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory W. Smith. The network helps show where Gregory W. Smith may publish in the future.

Co-authorship network of co-authors of Gregory W. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory W. Smith. A scholar is included among the top collaborators of Gregory W. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory W. Smith. Gregory W. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ammakkanavar, Natraj Reddy, et al.. (2017). Next generation sequencing in community oncology practice: Beneficial or economical burden?. Journal of Clinical Oncology. 35(15_suppl). 102–102. 4 indexed citations
2.
Rosenberg, Jonathan E., Richard Bambury, Eliezer M. Van Allen, et al.. (2013). A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Investigational New Drugs. 32(1). 178–187. 326 indexed citations
3.
4.
Drabkin, Harry A., Primo Lara, Andrea Harzstark, et al.. (2010). A phase II, single-arm study of AS1411 in metastatic renal cell carcinoma (RCC).. Journal of Clinical Oncology. 28(15_suppl). 4590–4590. 7 indexed citations
5.
Smith, Gregory W., et al.. (2010). Implementing a Referral to Telephone Tobacco Cessation Services in Louisiana Community Pharmacies: A Pilot Study. Annals of Pharmacotherapy. 44(9). 1395–1402. 15 indexed citations
6.
Self-Sullivan, Caryn, et al.. (2003). Seasonal occurrence of male Antillean manatees (<I>Trichechus manatus manatus</I>) on the Belize Barrier Reef. Aquatic Mammals. 29(3). 342–354. 20 indexed citations
7.
Smith, Gregory W., et al.. (2000). Science, technology and society in transition year: A pilot study. Irish Educational Studies. 19(1). 107–119. 10 indexed citations
8.
Weakliem, Paul C., Gregory W. Smith, & Emily A. Carter. (1990). Subpicosecond interconversion of buckled and symmetric dimers on Si(100). Surface Science. 232(3). L219–L223. 55 indexed citations
9.
Bukowski, Ronald M., Gregory W. Smith, & James E. Montie. (1988). Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms. Urology. 31(5). 403–407. 1 indexed citations
10.
Smith, Gregory W., Ronald M. Bukowski, James S. Hewlett, & C. W. Groppe. (1984). Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma. Cancer. 54(8). 1513–1516. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026